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Abstract
Background—Financial barriers to adult vaccination are poorly understood. Our objectives were 
to assess among general internists (GIM) and family physicians (FP) shortly after Affordable Care 
Act (ACA) implementation: 1) proportion of adult patients deferring or refusing vaccines because 
of cost and frequency of physicians not recommending vaccines for financial reasons; 2) 
satisfaction with reimbursement for vaccine purchase and administration by payer type; 3) 
knowledge of Medicare coverage of vaccines; and 4) awareness of vaccine-specific provisions of 
the ACA.
Methods—We administered an Internet and mail survey from June to October 2013 to national 
networks of 438 GIMs and 401 FPs.
Results—Response rates were 72% (317/438) for GIM and 59% (236/401) for FP. Among 
physicians who routinely recommended vaccines, up to 24% of GIM and 30% of FP reported adult 
patients defer or refuse certain vaccines for financial reasons most of the time. Physicians reported 
not recommending vaccines because they thought the patient’s insurance would not cover it (35%) 
or the patient could be vaccinated more affordably elsewhere (38%). Among physicians who saw 
patients with this insurance, dissatisfaction (‘very dissatisfied’) was highest for payments received 
from Medicaid (16 % vaccine purchase, 14 % vaccine administration) and Medicare Part B (11 % 
vaccine purchase, 11 % vaccine administration). Depending on the vaccine, 36–71% reported not 
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knowing how Medicare covered the vaccine. Thirty-seven percent were ‘not at all aware’ and 19% 
were ‘a little aware’ of vaccine-specific provisions of the ACA.
Conclusions—Patients are refusing and physicians are not recommending adult vaccinations for 
financial reasons. Increased knowledge of private and public insurance coverage for adult 
vaccinations might position physicians to be more likely to recommend vaccines and better enable 
them to refer patients to other vaccine providers when a particular vaccine or vaccines are not 
offered in the practice.
Introduction
Most deaths from vaccine preventable disease in the U.S are among adults, yet adult 
vaccination rates for most recommended vaccines remain low.1 National stakeholders in 
adult immunization have voiced concerns about gaps in financing for adult vaccines2 being 
one source of the problem and prior research3,4 suggests physicians view financial barriers 
as key contributors to low adult immunization rates. Comparatively, the U.S. pediatric 
vaccination program has been much more successful5 and benefits from the financial 
infrastructure of the Vaccines for Children program (VFC).6 Financial barriers to pediatric 
vaccination7–11 have been well-explored, but there has been little in-depth research of these 
barriers in the adult immunization program.
The current U.S. system for financing adult vaccine delivery is a mixture of public and 
private sector efforts, similar to the pediatric program, although there is not a comparable 
program to VFC for adults. Some of the provisions of the Affordable Care Act (ACA) aimed 
to address financial barriers to vaccination, but holes remain in the financial framework for 
adult vaccine delivery. The ACA mandates that non-grandfathered private health insurance 
plans cover Advisory Committee on Immunization Practices (ACIP) recommended vaccines 
without a copay when administered by an in-network provider, thus decreasing a financial 
barrier for patients. However, the law does not address payment to providers for vaccine 
purchase and administration.2 The ACA temporarily increased Medicaid reimbursement for 
vaccine administration to Medicare level ($21)11 which may have decreased physicians’ 
financial barriers to providing vaccines to Medicaid patients. However, the ACA did not 
mandate State Medicaid agencies do so and several State Medicaid agencies do not cover all 
ACIP recommended adult vaccines.12 The ACA did not affect vaccination coverage benefits 
in Medicare, the primary payer for adult vaccines for seniors.
Seasonal influenza vaccines, pneumococcal vaccines, hepatitis B vaccine for patients with 
certain conditions, and vaccines directly related to the treatment of an injury or direct 
exposure to a disease are covered by Medicare Part B. Over 90% of Medicare beneficiaries 
have Medicare Part B coverage.13 Vaccines not covered by Medicare Part B, must be 
covered by Medicare Part D plans and are subject to deductibles and copays for each 
individual vaccine. Not all Medicare beneficiaries have a Part D plan to cover these other 
vaccines; in 2015, 71% of seniors had Medicare Part D coverage.14
Little is known about physician awareness of Medicare coverage of vaccines or of the 
vaccine-specific provisions of the ACA. While physicians have reported concerns about 
reimbursement for adult vaccine delivery, this has not been assessed by payer type. Given 
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the important role financial barriers may play in patient and provider behaviors related to 
adult vaccine delivery, we conducted a survey to determine among general internists and 
family physicians nationally soon after ACA implementation: 1) the proportion of adult 
patients who defer or refuse vaccines because of cost and the frequency of physicians not 
recommending vaccines for financial reasons; 2) satisfaction with payment for vaccine 
administration and purchase by payer type; 3) knowledge of Medicare coverage of vaccines; 
and 4) awareness of vaccine-specific provisions of the ACA.
Methods
Study Setting
From June – October 2013, we administered a survey to a national network of physicians 
who spent at least half their time practicing primary care. The human subjects review board 
at the University of Colorado Denver approved this study as exempt research not requiring 
written informed consent.
Study Population
The Vaccine Policy Collaborative Initiative15, a survey mechanism to assess physician 
attitudes about vaccine issues in collaboration with the Centers for Disease Control and 
Prevention (CDC), conducted the survey. We developed a network of primary care 
physicians for this program by recruiting general internists (GIM) and family physicians 
(FP) from the memberships of the American College of Physicians (ACP) and the American 
Academy of Family Physicians (AAFP). We conducted quota sampling16 to ensure that 
networks of physicians were similar to the ACP and AAFP memberships with respect to 
region, urban versus rural location, and for GIM only, practice setting. We previously 
demonstrated that survey responses from network physicians compared to those of 
physicians randomly sampled from American Medical Association physician databases were 
similar with respect to reported demographic characteristics, practice attributes, and attitudes 
about vaccination issues.16
Survey Design
We developed the survey collaboratively with the CDC. We used 4-point Likert scales for 
assessing frequency of not recommending vaccines for financial reasons (‘Never’ to 
‘Frequently’), for satisfaction (‘Very satisfied’ to ‘Very dissatisfied’) with insurance payment 
for vaccine and administration fees for each payer type, and for whether physicians had 
considered stopping providing vaccines to patients with specific insurance types (‘never 
considered,’ ‘considered, but not seriously,’ ‘seriously considered or discussed,’ ‘already 
stopped providing all vaccines.’) Private payer types included fee for service (FFS), 
preferred provider organizations (PPO), and managed care (MCO) or health maintenance 
organizations (HMO). Public payer types included Medicaid and Medicare Parts B and D. 
We provided respondents with information about vaccine-specific provisions of the ACA 
and asked questions regarding their prior awareness of these provisions and whether these 
provisions would result in their practices changing stocking patterns of adult ACIP routinely 
recommended vaccines. A national advisory panel of GIM (n=3) and FP (n=4) pre-tested the 
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survey, which we modified based on their feedback. We pilot-tested the survey among 50 
GIM and 15 FP nationally and further modified based on their feedback.
Survey Administration
Based on physician preference, we sent the survey over the Internet17 or through the U.S. 
Postal Service. We sent the Internet group an initial e-mail with up to 8 e-mail reminders, 
and we sent the mail group an initial mailing and up to 2 additional reminders. Non-
respondents in the Internet group were also sent a mail survey in case of problems with e-
mail correspondence. We patterned the mail protocol on Dillman’s tailored design method.18
Statistical analysis
We pooled Internet and mail surveys for analyses because other studies have found that 
physician attitudes are similar when obtained by either method18–20. We compared 
respondents with non-respondents on all available characteristics using Wilcoxon and chi-
square analyses; characteristics of non-respondents were obtained from the recruitment 
survey for the sentinel networks. We compared GIM and FP responses using Mantel-
Haenszel chi square and Fisher’s Exact tests. With the exception of reported proportion of 
patients who defer or refuse vaccines for financial reasons and reported satisfaction with 
reimbursement by payer type, responses between specialties were similar and are, therefore, 
presented together. For comparisons between public (Medicaid, Medicare Parts B & D) and 
private insurance (HMO/MCO, PPO, FFS) we compared the proportion who responded 
‘very dissatisfied’ to any payer in that group using chi-square analyses. Analyses were 
performed using SAS software, version 9.4 (SAS Institute, Cary, North Carolina).
Results
Survey response and characteristics of respondents
Response rates were 72% for GIM (317/438) and 59% for FP (236/401). Respondents and 
non-respondents did not differ significantly by age, region, practice location, or practice 
setting. Among GIM physicians, males were less likely to respond (p=0.02). Characteristics 
of respondents, their practices and their patient populations are shown in Table 1. Of those 
who responded, 19 (9 GIM and 10 FP) reported they do not give immunizations to adult 
patients and were excluded from further analysis leaving a final cohort of 534 (308 GIM, 
226 FP).
Proportion of adults who defer or refuse vaccines for financial reasons
Figure 1 shows, among physicians who recommended each vaccine, the percentage of 
physicians who reported patients deferring or refusing vaccines because of out-of-pocket 
costs or insufficient insurance coverage in a typical month. Zoster, hepatitis B, and HPV 
vaccines were most commonly reported as deferred or refused.
Frequency of physicians not recommending an adult vaccine for financial reasons
Figure 2 demonstrates the frequency within the last year that physicians have reported not 
recommending a vaccine to an adult for various financial reasons. Over one-third of 
Hurley et al. Page 4
Vaccine. Author manuscript; available in PMC 2018 January 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
physicians reported they had not recommended vaccines ‘frequently’ or ‘sometimes’ 
because they either thought the patient’s insurance would not cover it or that the patient 
could receive the vaccine more affordably elsewhere; nearly one-quarter had not 
recommended vaccination believing that the patient could not afford it.
Satisfaction with Insurance Payment
Physicians’ level of satisfaction with insurance payment for vaccine purchase and vaccine 
administration by insurance type is shown in Figure 3. Almost half of the physicians were 
not knowledgeable about their level of satisfaction with payment by payer. However, across 
all payers, 6 to 16 % were ‘very dissatisfied’ with payment for vaccine purchase and 5 to 
14 % were ‘very dissatisfied’ with payment for vaccine administration. There were 402/534 
physicians (75%) who saw all insurance types and had non-missing values for satisfaction 
for vaccine purchase. Of those, 19% (n=75) reported being ‘very dissatisfied’ with any 
public payer, compared to 7% (n=28, p<.0001) who reported being ‘very dissatisfied’ with 
any private payer. There were 401/534 (75%) who saw all insurance types and had non-
missing values for satisfaction for vaccine administration. Of those, 16% (n=66) reported 
being ‘very dissatisfied’ with any public payer, compared to 6% (n=23, p<.0001) who 
reported being ‘very dissatisfied’ with any private payer. Of physicians seeing patients with 
each specific insurance type, 12% (48/417), 11% (49/455), 11% (52/467) and 7% (32/485) 
had seriously considered stopping to provide all vaccines to patients with Medicaid, 
Medicare Part D, Medicare Part B and private insurance, respectively, due to vaccine cost, 
administration fee, and/or reimbursement issues in the past twelve months. Less than 5% of 
physicians had actually stopped providing vaccines for any payment type.
Knowledge of Medicare coverage of vaccines
Eighty-three (n=425/512) percent of respondents reported their practice had a contractual 
relationship with Medicare. Of these respondents, 41% reported billing, 29% reported not 
billing, and 29% reported they ‘do not know’ if their practices bill Medicare Part D for adult 
vaccines provided in the practice. Only 9% of these respondents were aware of TransactRx-a 
web portal through which practices can electronically submit claims for reimbursement for 
Medicare Part D vaccines and administration. Of those who were aware of it, only 46% 
(n=16) reported being members of TransactRx. Physicians who reported having a 
contractual relationship with Medicare were also asked, as of January 2013, through what 
parts of Medicare various vaccines are reimbursed for beneficiaries (see Table 2). Large 
proportions, and often the majority of physicians, were not knowledgeable about Medicare 
coverage for vaccines. They were most knowledgeable about Medicare coverage for 
seasonal influenza, PPSV23, and zoster vaccines.
Awareness of and anticipated changes as a result of vaccine specific provisions of the 
Affordable Care Act
Eleven percent of physicians were ‘very aware,’ 33% were ‘somewhat aware,’ 19% were ‘a 
little aware,’ and 37% were ‘not at all aware’ of the vaccine specific provisions of the 
Affordable Care Act. As a result of the ACA provisions, 71% of physicians reported their 
practice would not change, 8% would increase, and 1% would decrease the number of ACIP 
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recommended adult vaccines their practice stocks. Twenty percent ‘did not know’ how these 
ACA provisions would affect their practice’s adult vaccine stocking patterns.
Discussion
While previous studies have documented physician reported financial barriers to adult 
vaccination,3,4 ours is the first to describe the implications of these financial barriers in 
practice. Many physicians reported not recommending vaccinations to their adult patients 
and patients frequently refusing vaccines for financial reasons. Physician satisfaction with 
reimbursement for delivering adult vaccines had not been previously reported. Although 
almost half of physicians were not knowledgeable about reimbursement, up to one-third of 
the knowledgeable physicians were dissatisfied with insurance payment for both vaccine 
purchase and vaccine administration across payer types. Physicians were most dissatisfied 
with public sector payers, primarily Medicaid followed by Medicare Parts B and D. Finally, 
we found that physicians lacked knowledge about coverage of adult vaccinations under 
Medicare and had limited awareness of vaccine-specific provisions of the ACA.
Physician recommendation is critical to patient receipt of vaccines,21–25 yet we found that 
physicians are not recommending vaccines to adults for financial reasons. Regardless of 
actual insurance coverage, if physicians perceive that vaccines are not covered, they may not 
recommend them. We are not certain why physicians would not recommend vaccines 
because patients could receive them more affordably elsewhere. This might relate to 
vaccines covered by Medicare Part D being more easily being billed for by pharmacists26 or 
that patients might receive vaccines at no charge by public health departments using federal 
funds for the underserved to fund the vaccination. According to National Vaccine Advisory 
Committee standards for adult immunization,27 providers should strongly recommend 
vaccines regardless of where they might be received.
Since the first US adult immunization schedule was published in 200228, several vaccines 
have been added, substantially increasing the complexity of the schedule and increasing the 
cost of obtaining all ACIP recommended vaccines for adults.29–36
Newly recommended vaccines are generally more expensive,10,37 and, in this study, 
physicians perceived that some of the new, more expensive vaccines, zoster and HPV 
vaccine, were deferred or refused by more patients than other vaccines for financial reasons. 
While PCV13 and meningococcal vaccine are also expensive, there are reasons physicians 
may have perceived these vaccines being refused by less patients. The PCV13 vaccine 
recommendation at the time of this study was new and targeted certain 
immunocompromised individuals less than sixty-five years-old, potentially a small 
proportion of a physician’s patient population. Similarly, the adult meningococcal vaccine 
recommendation targets certain high-risk adults that might not have accounted for many 
patients in the practice. It is notable physicians reported very few patients declining seasonal 
influenza or PPSV-23 vaccines for financial reasons as both of these vaccine are covered by 
Medicare Part B under which patients are not subject to copays. The fact that physicians 
perceive that several patients are refusing zoster and HPV vaccines for financial reasons 
implies that either patients are uninsured or that patient cost-sharing for vaccines can be 
Hurley et al. Page 6
Vaccine. Author manuscript; available in PMC 2018 January 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
substantial even when a patient is insured. The ACA has expanded health insurance coverage 
for millions of Americans38 and thus expanded coverage to recommended vaccines. 
However, patients covered by some grand-fathered private health insurance plans, some 
State Medicaid programs, and Medicare Part D may still be experiencing incomplete 
coverage and/or prohibitive beneficiary cost-sharing. With new vaccines under development 
like the new zoster vaccine,39 it could be helpful to consider how patient insurance coverage 
and cost to procure a vaccine will impact vaccine delivery.
While almost the majority of physicians reported they were not knowledgeable about their 
satisfaction with reimbursement, those that were knowledgeable reported dissatisfaction 
across payer types, but mostly with public insurance. Some physicians had stopped or had 
seriously considered stopping to provide vaccines to patients with these insurance types. 
Medicaid topped the list for both dissatisfaction with vaccine purchase and administration. A 
prior study evaluating pediatric vaccines also found higher levels of dissatisfaction with 
Medicaid payment for administration fees.11 Before the temporary increase in Medicaid 
vaccine administration fees to Medicare levels brought on by the ACA, Medicaid vaccine 
administration fees were as low as $2.40 It is unclear if physician respondents were aware of 
or changed their practice as a result of the temporary increased vaccine administration fee 
for Medicaid patients; this survey launched in the first year of increased payment so 
physicians may not have been aware of the increase and physicians were generally unaware 
of the vaccine-specific provisions of the ACA. However, physicians were almost equally 
dissatisfied with vaccine administration payment through Medicare Part B and D despite 
Medicare paying considerably more for vaccine administration than many state Medicaid 
programs,41 so this time-limited increase in payment might have been inconsequential. The 
Infectious Diseases Society of America has suggested that the Centers for Medicare and 
Medicaid Services (CMS) should work to assure physician billing codes adequately cover 
the full costs of providing immunizations42,43 and to do this CMS may require updated 
information about how much it actually costs to immunize an adult.2
Dissatisfaction with reimbursement for vaccines covered by Medicare Part B has not been 
previously reported. Previous research did not ask specifically about satisfaction with 
reimbursement by payer type, but did find that perceiving a higher financial burden from 
delivering adult vaccines was correlated with having a higher proportion of Medicare Part D 
patients.4 The only way a physician can bill for a Medicare Part D vaccine is through 
TransactRx,44 a web-portal which physicians’ can use for billing purposes. Although 41% of 
physicians reported billing Medicare Part D for vaccines, only 9% were aware of Transact 
Rx. This finding could be explained by respondents not being fully aware of details of 
vaccine billing processes. Also, physician knowledge of Medicare coverage for vaccines was 
poor and therefore physicians might not have accurately distinguished Medicare Part B and 
D in their responses. The Infectious Diseases Society of America45 and the Medicare 
Payment Advisory Commission,46 have suggested that all adult vaccines recommended for 
Medicare beneficiaries be moved to Medicare Part B; however, this may not be feasible due 
to the significant implications for the U.S government’s budget. Having some vaccines 
covered under Medicare Part D allows patients to share in the cost of vaccines through 
deductibles and copays. Increased knowledge of Medicare coverage and billing would help 
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physicians determine which vaccines they can make available to their patients and, when this 
is not possible, where they should refer patients for vaccination.
Our study has strengths and limitations. Results were generated from general internists and 
family physicians from across the nation and we achieved an excellent response rate for a 
physician survey.47 Although the sample of sentinel physicians surveyed was designed to be 
representative of ACP and AAFP memberships, the attitudes, experiences, and practices of 
sentinel physicians may not be fully generalizable. Non-respondents may have held different 
views than respondents. The survey relied on self-report of practice rather than observation 
of practice. Respondents may have been too unfamiliar with vaccine financing in their 
practice to respond accurately.
Physicians perceive financial barriers to adult vaccination that are interfering with vaccine 
delivery and need more guidance on Medicare coverage of vaccines. Our data indicate that 
lack of understanding regarding Medicare coverage for vaccines and vaccine-relevant 
provisions of the ACA may be affecting physicians’ strength of recommendation and where 
they refer patients for vaccination; thus jeopardizing widespread adoption of National 
Vaccine Advisory Committee adult immunization standards to assess immunizations at 
every visit, strongly recommend needed vaccines and either administer or refer patients for 
vaccines.27 Even with the ACA vaccine-specific provisions, gaps remain in the financial 
infrastructure of adult vaccines in terms of prohibitive costs to patients and perceived 
insufficient reimbursement for physicians, particularly from public sector payers. Efforts to 
address these gaps will require further investigation into the perceived barriers created by 
Medicaid and Medicare reimbursement and physician costs to provide adult vaccines.
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Figure 1. Among Physicians Who Routinely Recommend Each Vaccine, Reported Proportion of 
Patients Who Defer/Refuse Vaccination due to Financial Reasons in a Typical Month*
The following proportions of physicians for GIM and FP, respectively, were excluded from 
the analysis for the vaccines he/she did not recommend: Zoster (GIM-1%, FP-3%), Hepatitis 
B (18%, 16%), Tdap (2%, 1%), Hepatitis A (27%, 28%), HPV (22%, 7%), Meningococcal 
(26%, 14%), Varicella (39%, 17%), Td (6%, 10%), PCV13 (17%, 17%), PPSV23 (3%, 2%), 
MMR (30%, 16%).
+p<0.05 for difference in reported vaccination defer/refusal due to financial reasons between 
GIM and FP, Mantel-Haenszel χ2 Square.
GIM = general internists; FP = family medicine physicians; Tdap = tetanus, diphtheria, 
acellular pertussis; HPV = Human Papillomavirus; Td = tetanus, diphtheria; PCV13 = 
Pneumococcal conjugate vaccine; PPSV23 = pneumococcal polysaccharide vaccine; and 
MMR = measles, mumps, rubella
Vaccine prices were obtained from the CDC Vaccine Price List for the private sector: http://
www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html.
Hurley et al. Page 12
Vaccine. Author manuscript; available in PMC 2018 January 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Frequency of Not Recommending Vaccination for Financial Reasons in the Past Year 
(GIM, n=308 and FP, n=226)*
*No significant differences found comparing specialties using Mantel-Haenszel chi-squared 
test.
GIM = General Internal Medicine; FP = Family Practice
Hurley et al. Page 13
Vaccine. Author manuscript; available in PMC 2018 January 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 3. Satisfaction with Payment for Vaccine Purchase and Administration by Payer, 
(n=499)+
+4.5–14.6% of respondents indicated that they do not see patients in this group or do not bill 
this insurance, and therefore are not included in the figure.
*Comparison between specialties, with GIM more likely to report dissatisfaction with 
payment for vaccine purchase than FP for Medicaid (p=0.01), Medicare Part B (p=0.03), and 
FFS (p=0.04) by X2 analysis.
ˆComparison between specialties with GIM more likely to report dissatisfaction with 
payment for vaccine administration than FP for PPO (p=0.02) by X2 analysis.
MCO/HMO = managed care organization/health maintenance organization; PPO = preferred 
provider organization; FFS = fee for service.
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Table 1
Respondent and Non-Respondent Characteristics
Characteristic GIM FP
Respondents
(n=317)
Non-Respondents
(n=121)
Respondents
(n=236)
Non-Respondents
(n=165)
Age in years, mean (SD) 52.9 (8.8) 52.0 (9.5) 52.9 (9.9) 50.9 (10.1)
Male, % 62* 74* 56 61
Region, %
 Midwest 19 27 31 26
 Northeast 27 23 16 16
 South 32 34 30 41
 West 23 16 23 18
Location of Practice, %
 Urban 46 40 25 24
 Suburban 41 46 46 51
 Rural 13 15 29 25
Setting, %
 Private practice 80 79 7 74
 Hospital/clinic 17 18 24 20
 HMO 4 3 6 6
# of physicians in your practice, %
 1 15 21
 2–4 27 39
 5–10 29 25
 ≥10 29 14
Physicians providing vaccines to adults, % 97 96
Proportion of patients ≥ 65,%
 <10% 4 12
 10–24% 17 36
 25–49% 45 37
 ≥50% 34 14
Patients with Medicare Part B,%
 <10% 7 16
 10–24% 18 31
 25–49% 42 35
 ≥50% 24 10
 Don’t know 10 7
Patients with Medicare Part D,%
 <10% 9 19
 10–24% 26 34
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Characteristic GIM FP
Respondents
(n=317)
Non-Respondents
(n=121)
Respondents
(n=236)
Non-Respondents
(n=165)
 25–49% 30 22
 ≥50% 20 6
 Don’t know 15 19
*p<0.05 for comparison of respondents and non-respondents
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Table 2
Among Providers Accepting Medicare, Knowledge of Medicare Coverage of Vaccines (n=425)*
Vaccine Medicare Coverage Correct (%) Incorrect (%) Didn’t Know (%)
Seasonal influenza Part B 59 5 36
PPSV23 Part B 54 5 41
Zoster Part D 51 5 43
PCV13 Part B 40 5 55
Td Part B 36 10 54
Hepatitis B Part B 27 8 66
Tdap Part D 17 26 58
Hepatitis A Part D 8 21 71
Tdap = tetanus, diphtheria, acellular pertussis; HPV = human papillomavirus; Td = tetanus, diphtheria; PCV13 = pneumococcal conjugate; and 
PPSV23 = pneumococcal polysaccharide
*No significant differences found comparing specialties using Mantel-Haenszel chi-squared test.
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